Fintel reports that on December 2, 2024, Leerink Partners initiated coverage of IDEXX Laboratories (DB:IX1) with a Outperform recommendation.
Analyst Price Forecast Suggests 25.42% Upside
As of October 21, 2024, the average one-year price target for IDEXX Laboratories is 501,57 €/share. The forecasts range from a low of 376,78 € to a high of 586,89 €. The average price target represents an increase of 25.42% from its latest reported closing price of 399,90 € / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for IDEXX Laboratories is 4,093MM, an increase of 6.46%. The projected annual non-GAAP EPS is 11.17.
What is the Fund Sentiment?
There are 2,050 funds or institutions reporting positions in IDEXX Laboratories. This is an increase of 4 owner(s) or 0.20% in the last quarter. Average portfolio weight of all funds dedicated to IX1 is 0.31%, an increase of 6.95%. Total shares owned by institutions decreased in the last three months by 2.50% to 87,264K shares.
What are Other Shareholders Doing?
Alliancebernstein holds 2,818K shares representing 3.44% ownership of the company. In its prior filing, the firm reported owning 3,145K shares , representing a decrease of 11.60%. The firm increased its portfolio allocation in IX1 by 21.72% over the last quarter.
Fundsmith LLP holds 2,664K shares representing 3.25% ownership of the company. In its prior filing, the firm reported owning 2,663K shares , representing an increase of 0.04%. The firm increased its portfolio allocation in IX1 by 0.70% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 2,607K shares representing 3.18% ownership of the company. In its prior filing, the firm reported owning 2,611K shares , representing a decrease of 0.13%. The firm decreased its portfolio allocation in IX1 by 2.73% over the last quarter.
Geode Capital Management holds 2,260K shares representing 2.76% ownership of the company. In its prior filing, the firm reported owning 2,219K shares , representing an increase of 1.79%. The firm decreased its portfolio allocation in IX1 by 49.00% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 2,156K shares representing 2.63% ownership of the company. In its prior filing, the firm reported owning 2,120K shares , representing an increase of 1.69%. The firm decreased its portfolio allocation in IX1 by 2.93% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
